Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002392636 | SCV002703357 | uncertain significance | Inborn genetic diseases | 2022-01-30 | criteria provided, single submitter | clinical testing | The p.K3491N variant (also known as c.10473A>C), located in coding exon 55 of the DYNC1H1 gene, results from an A to C substitution at nucleotide position 10473. The lysine at codon 3491 is replaced by asparagine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003096963 | SCV003272301 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2023-06-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003408268 | SCV004113970 | uncertain significance | DYNC1H1-related disorder | 2022-09-19 | criteria provided, single submitter | clinical testing | The DYNC1H1 c.10473A>C variant is predicted to result in the amino acid substitution p.Lys3491Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/14-102500372-A-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |